Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2 in the footer, indicating a deployment/version update. This represents a metadata update related to the site's software version.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants. The study record revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check25 days agoChange DetectedThe record history updates to include revision v3.5.5 as the current version and removes revision v3.5.4 from the list, indicating a page-level version update.SummaryDifference0.0%

- Check47 days agoChange DetectedThe Record History now includes a new revision tag v3.5.4. The previous revision v3.5.3 is removed from the history list.SummaryDifference0.0%

- Check69 days agoChange DetectedThis update reflects a change to the site’s interface/version label (revision v3.5.3 instead of v3.5.2) without altering the underlying clinical trial record history content.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded a new revision entry v3.5.2 and removed the v3.5.0 entry from the history.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.